Security key
71678J209
Petros Pharmaceuticals, Inc. - Common Stock, $0.0001 par value (PTPI)
CUSIP: 71678J209
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / Common Stock, $0.0001 par value
- Shares outstanding
- 25,296,136
- Total 13F shares
- 97,688
- Share change
- -68,211
- Total reported value
- $38,483
- Reported price per share
- $0.39
- Number of holders
- 9
- Value change
- -$25,561
- Number of buys
- 1
- Number of sells
- 5
Security identity
Holder snapshot
Report period
Q4 2024
Institutions
9
Top holders
9
PTPI full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2025
Previous quarter: Q3 2024
Petros Pharmaceuticals, Inc. SEC filings
Petros Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 71678J209
Recent filing periods:
Ownership snapshot
Top shareholders of PTPI - Petros Pharmaceuticals, Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
Ayrton Capital LLC
13D/G signal
Ayrton Capital LLC
Evidence rows
15
Latest as of
31 Dec 2024
13D/G
13F
3/4/5
Lead comparable stake: 6.2%
13D/G row: Ayrton Capital LLC
Showing first 8 of 15 holder rows.
Open remaining rows
Rank 1 holder
Ayrton Capital LLC
13D/G
- Ownership
- 6.2%
- Position
- $6.6K
Rank 2 holder
UBS Group AG
13F
- Ownership
- 0.17%
- Position
- $15.8K
Rank 3 holder
GEODE CAPITAL MANAGEMENT, LLC
13F
- Ownership
- 0.15%
- Position
- $13.4K
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Ayrton Capital LLC |
13D/G
|
6.2%
|
$6,576
657,614 shares
|
$0 | 31 Dec 2024 |
| UBS Group AG |
13F
Company
|
0.17%
|
$15,787
44,221 shares
|
— | 30 Sep 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.15%
|
$13,393
37,517 shares
|
— | 30 Sep 2024 |
| TWO SIGMA SECURITIES, LLC |
13F
Company
|
0.13%
|
$11,525
32,284 shares
|
— | 30 Sep 2024 |
| VANGUARD GROUP INC |
13F
Company
|
0.13%
|
$11,357
31,811 shares
|
— | 30 Sep 2024 |
| BlackRock, Inc. |
13F
Company
|
0.06%
|
$5,758
16,128 shares
|
— | 30 Sep 2024 |
| Tower Research Capital LLC (TRC) |
13F
Company
|
0.01%
|
$1,162
3,255 shares
|
— | 30 Sep 2024 |
| NATIONAL BANK OF CANADA /FI/ |
13F
Company
|
0%
|
$112
313 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
9
Shares
97,688
Rows loaded
9
| Investor | Option | Weight % | Change % | Reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
11
Q4 2024 holders
9
Holder diff
-2
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 value | Q4 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend